Liz Highleyman

42% of ALL patients who received Aucatzyl immunotherapy, made from their own T cells, experienced complete remission within three months.

People treated with the fatty acid synthase inhibitor saw significant improvements in disease activity, liver fibrosis and MASH resolution.

Recent studies showed that a drug approved for schizophrenia and a cannabis extract relieved nausea and improved quality of life.

People who talked with their doctors about physical activity were 21% less likely to experience falls.

The new injectable formulation of Tecentriq reduces treatment time to seven minutes compared with up to an hour for IV infusions.

However, study results suggest higher doses may benefit patients with tumors on the left side of the colon or rectum.

Rybrevant plus Lazcluze is approved as first-line treatment for people with advanced non-small-cell lung cancer with EGFR mutations.

Zynyz immunotherapy added to chemotherapy extended progression-free survival and may improve overall survival.

Lorbrena is a next-generation targeted therapy that interferes with ALK, a protein that plays a role in cell growth.

Overweight and obesity have been linked to at least 13 different cancers.

A cancer diagnosis can change your sex life, but patience, experimentation and communication can help you get back on track.

Enhertu is an antibody-drug conjugate that uses a monoclonal antibody to deliver toxic chemotherapy directly to tumors.

Oncology palliative care is intended to relieve symptoms and improve quality of life.

Each household will be able to order four at-home tests starting in late September.

Two tests appear to be better than one for accurately detecting anal cancer.